Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044291
Status:
COMPLETED
Last Update Posted:
2015-07-31
First Post:
2002-08-23
Brief Title:
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Sponsor:
Intarcia Therapeutics
Organization:
Intarcia Therapeutics
Organization Data
Organization:
Intarcia Therapeutics
Class:
INDUSTRY
Study ID:
Biomed 777-CLP-29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Intarcia Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None